30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Jewell Christopher M

Track

Insider profile

Performance

Overall performance
1.9
Performance over holding periods
1.9
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Jewell Christopher M's trades of Cartesian Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-13 2026-01-13
PrS Proposed sale
22,935
323.78
US$3,356,299 		22,935 323.78 US$3,356,299
2026-01-09 2026-01-09
PrS Proposed sale
28,877
304.60
US$1,305,617 		28,877 304.60 US$1,305,617
2025-11-19 2025-11-19
PrS Proposed sale
33,047
423.73
US$2,484,322 		33,047 423.73 US$2,484,322
2025-01-07 2025-01-06
S Sale
1,286 -2.3%
16.83
US$21,646 		1,286 -2.3% 16.83 US$21,646
2025-01-07 2025-01-03
S Sale
1,264 -2.3%
16.72
US$21,136 		1,264 -2.3% 16.72 US$21,136
2024-11-18 2024-11-15
S Sale
16,065 -38.2%
17.06
US$274,093 		16,065 -38.2% 17.06 US$274,093
2024-11-15 2024-11-15
PrS Proposed sale
16,065
17.06
US$274,093 		16,065 17.06 US$274,093
2024-11-18 2024-11-14
S Sale
17,500 -40.3%
17.02
US$297,824 		17,500 -40.3% 17.02 US$297,824
2024-11-18 2024-11-14
S Sale
18,550 -29.9%
16.34
US$303,126 		18,550 -29.9% 16.34 US$303,126
2024-11-14 2024-11-14
PrS Proposed sale
36,050
16.67
US$600,949 		36,050 16.67 US$600,949